NEW APPROACHES FOR GENERATING CATALYTIC ANTIBODIES
生成催化抗体的新方法
基本信息
- 批准号:2838611
- 负责人:
- 金额:$ 10.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-12-01 至 1999-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The majority of research in the field of catalytic antibodies has been
directed toward the discovery of new chemical reactions that can be
catalyzed by antibodies. While it is now clear from this work that a large
number of reactions are amenable to antibody catalysis, the standard
first-generation catalysts reported in these studies have poor activity
compared to natural enzymes. We are interested in developing new methods
that produce catalytic antibodies with higher activity, and in
understanding structure/function relationships in antibody catalysis that
will allow higher activity variants of first-generation catalysts to be
engineered. We recently generated a hydrolytic antibody that catalyzes
enantioselective amino acid ester and amide hydrolysis. This is one of the
best catalytic antibodies generated to date for esterase activity (kcat=4
sec-1), and our preliminary mechanistic studies indicate that the antibody
uses a mechanism of catalysis that is similar to serine proteases. In
addition, we have solved the 3-dimensional crystal structure of this
antibody with bound hapten at 2.5 Angstroms resolution (in collaboration
with Robert Fletterick's group at UCSF). The active site structure is
consistent with our kinetic data and further supports the mechanistic
analogy with serine proteases. With this system, we have an unparalleled
opportunity to delineate the important structure/function relations for
hydrolytic antibodies and create more active variants of our first-
generation catalyst. This proposal describes mechanistic studies, amidase
kinetic analyses, mutagenesis studies, and an amidase-based functional
selection in hybridomas that are designed around our unique catalytic
antibody system. The mechanistic experiments are aimed at proving the
existence of a covalent intermediate in catalysis and identifying whether
intermediate formation or breakdown is rate-limiting. We propose to
develop a more sensitive radioisotope assay to accurately measure the
kinetics of antibody-catalyzed amide hydrolysis. Our mutagenesis studies
are designed to identify catalytically important residues in the antibody
active site, and construct more active antibody mutants that are improved
in both kcat and KM. With our functional selection in hybridomas we intend
to probe the immunoglobulin repertoire for antibodies that are better at
catalyzing amide hydrolysis. The results of this research could
significantly advance the field of catalytic antibodies by defining the
limits of catalytic activity that can be incorporated into an
immunoglobulin combining site and providing new selection-based methods
for generating catalytic antibodies with higher levels of activity.
催化抗体领域的大部分研究都是
旨在发现新的化学反应
由抗体催化。虽然现在从这项工作中可以清楚地看出,
抗体催化反应的数量,标准
这些研究报告的第一代催化剂活性较差
与天然酶相比。我们有兴趣开发新方法
产生具有更高活性的催化抗体,并且
了解抗体催化中的结构/功能关系
将允许第一代催化剂的更高活性变体
设计的。我们最近产生了一种水解抗体,可以催化
对映选择性氨基酸酯和酰胺水解。这是其中之一
迄今为止产生的酯酶活性最佳催化抗体(kcat=4
sec-1),我们的初步机制研究表明该抗体
使用类似于丝氨酸蛋白酶的催化机制。在
此外,我们还解决了这个的3维晶体结构
具有 2.5 埃分辨率的结合半抗原的抗体(合作
与加州大学旧金山分校 (UCSF) 的罗伯特·弗莱特里克 (Robert Fletrick) 小组合作)。活性位点结构为
与我们的动力学数据一致,进一步支持了该机制
与丝氨酸蛋白酶类比。有了这个系统,我们就拥有了无与伦比的
有机会描述重要的结构/功能关系
水解抗体并创建我们的第一个的更活跃的变体
生成催化剂。该提案描述了机制研究、酰胺酶
动力学分析、诱变研究和基于酰胺酶的功能
围绕我们独特的催化设计的杂交瘤的选择
抗体系统。机械实验旨在证明
催化中是否存在共价中间体并确定是否存在
中间形成或分解是限速的。我们建议
开发一种更灵敏的放射性同位素测定法来准确测量
抗体催化酰胺水解的动力学。我们的诱变研究
旨在识别抗体中具有催化作用的重要残基
活性位点,并构建更具活性的改良抗体突变体
在 kcat 和 KM 中。通过我们对杂交瘤的功能选择,我们打算
探索免疫球蛋白库,寻找更擅长的抗体
催化酰胺水解。这项研究的结果可以
通过定义显着推进催化抗体领域
可以纳入的催化活性的限制
免疫球蛋白结合位点并提供新的基于选择的方法
用于产生具有更高活性水平的催化抗体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS Sterling SCANLAN其他文献
THOMAS Sterling SCANLAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS Sterling SCANLAN', 18)}}的其他基金
Chemical Biology Studies of 3-Iodothyronamine and Related Thyroid Hormone Metabol
3-碘甲腺胺及相关甲状腺激素代谢的化学生物学研究
- 批准号:
8464697 - 财政年份:2012
- 资助金额:
$ 10.53万 - 项目类别:
Chemical Biology Studies of 3-Iodothyronamine and Related Thyroid Hormone Metabol
3-碘甲腺胺及相关甲状腺激素代谢的化学生物学研究
- 批准号:
8235583 - 财政年份:2012
- 资助金额:
$ 10.53万 - 项目类别:
Chemical Biology Studies of 3-Iodothyronamine and Related Thyroid Hormone Metabol
3-碘甲腺胺及相关甲状腺激素代谢的化学生物学研究
- 批准号:
8665414 - 财政年份:2012
- 资助金额:
$ 10.53万 - 项目类别:
相似海外基金
ABZYME CATALYZED SITE-SPECIFIC ACYLATION OF PROTEINS
ABZYME 催化的蛋白质位点特异性酰化
- 批准号:
2608715 - 财政年份:1997
- 资助金额:
$ 10.53万 - 项目类别:
ABZYME CATALYZED SITE-SPECIFIC ACYLATION OF PROTEINS
ABZYME 催化的蛋白质位点特异性酰化
- 批准号:
2173187 - 财政年份:1997
- 资助金额:
$ 10.53万 - 项目类别:
MOLECULAR GENETICS TO STUDY AND IMPROVE ABZYME FUNCTION
利用分子遗传学研究和改善 ABZYME 功能
- 批准号:
3044370 - 财政年份:1989
- 资助金额:
$ 10.53万 - 项目类别: